SRA-444

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Alzheimer DiseaseAlzheimer's Disease

Phase 1

Single Ascending Dose Study of SRA-444 in Healthy Subjects

CompletedNCT00452504

Wyeth is now a wholly owned subsidiary of PfizerAlzheimer Disease

Start: 2007-02-28End: 2007-06-30Target: 64Updated: 2007-12-05

Study Evaluating Safety, Tolerability, Pharmacokinetics and 5 HT1A Receptor Occupancy

CompletedNCT00499200

Wyeth is now a wholly owned subsidiary of PfizerAlzheimer's Disease

Start: 2007-10-31End: 2008-06-30Updated: 2008-07-09